Skip to main content
Clinical Trials/NCT04096261
NCT04096261
Withdrawn
Not Applicable

The Importance of Sleep Quality and the Blood-brain Barrier in Cognitive Disorders and Alzheimer's Disease

Charite University, Berlin, Germany1 site in 1 countrySeptember 12, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Blood Brain Barrier Defect
Sponsor
Charite University, Berlin, Germany
Locations
1
Primary Endpoint
Marker of blood-brain dysfunction using MRI
Status
Withdrawn
Last Updated
3 years ago

Overview

Brief Summary

The aim of our study is the analysis of sleep phases and quality as well as the detection of respiratory pauses in subjects with cognitive disorder. To assess whether sleep quality is associated with the blood-brain barrier and Alzheimer's disease, which may be indicative of an early, non-invasively measurable change in brain activity in the early stages of Alzheimer's disease.

Detailed Description

The aim of our study is the analysis of sleep phases and quality as well as the detection of respiratory pauses in subjects with cognitive disorder. To assess whether sleep quality is associated with the blood-brain barrier and Alzheimer's disease, which may be indicative of an early, non-invasively measurable change in brain activity in the early stages of Alzheimer's disease. Sleep quality impairment is a known risk factor for memory impairment. There is increasing evidence of a link between measurable sleep parameters, in particular a reduction of slow waves of deep sleep in cognitive deficits. Also, breathing pauses during sleep are associated with increased daytime sleepiness and cognitive impairment. This observational study is intended to establish a possible link between subjective memory disturbances and altered sleep quality or respiratory breaks during sleep. In the run-up to this study, they performed a special MRI scan of the head and a lumbar puncture (removal of nerve water) in a different context. The aim of this imaging study and the new biomarker in brain water was to investigate the function of the blood-brain barrier that occurs in Alzheimer's disease. The results of the studies on the quality of sleep should be evaluated in the context of this study in connection with the findings of the MRI examination and lumbar puncture.

Registry
clinicaltrials.gov
Start Date
September 12, 2019
End Date
December 31, 2019
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Oliver Peters, MD

Prof. Dr.

Charite University, Berlin, Germany

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Marker of blood-brain dysfunction using MRI

Time Frame: 1 day

Dynamic T1 contrast enhanced sequence using Gadovist

Markers of blood-brain dysfunction using CSF

Time Frame: 1 day

Platelet-derived growth factor receptor-β in CSF

Sleep quality measurement

Time Frame: 2 day

Polysomnography

Study Sites (1)

Loading locations...

Similar Trials